Brief: Mabion Signs Statement Of Work With UK-Based Company

Mabion SA

16/08/2024 07:42

Aug 16 (Reuters) - Mabion SA  MABP.WA :
    * SIGNS STATEMENT OF WORK WITH UK-BASED IMMUNOTHERAPY
COMPANY
    * VALUE OF WORK COMMISSIONED BY SOW IS ABOUT 5.5 MILLION
ZLOTYS
    * WILL BEGIN IMPLEMENTATION OF WORKS FOR CLIENT IN SEPT.
2024, AND
COMPLETION IS PLANNED FOR Q2, 2025
    * DEAL CONCERNS AMONG OTHERS PROCESS TRANSFER, MANUFACTURING
AND
RELEASE OF PRODUCT FOR CLINICAL USE

Source text for Workspace:  ID:nEM526KdJa 
Further company coverage:  MABP.WA 

 (Reporting by Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))